TCG Crossover Management »

Compass Pathways shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Compass Pathways (CMPS) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Compass Pathways

Tip: Access up to 7 years of quarterly data

All positions including Compass Pathways held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Pathways by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $29M 3.9M 7.40

More positions owned by TCG Crossover Management

Structure Therapeutics Adrs (GPCR)
Cogent Biosciences Comm (COGT)
Geron Corp Comm (GERN)
AN2 Therapeutics Comm (ANTX)
Savara Comm (SVRA)
Taysha Gene Therapies Comm (TSHA)
Kalvista Pharmaceuticals Comm (KALV)
Inhibrx Comm (INBX)
Aerovate Therapeutics Comm (AVTE)
Icosavax Comm
Compass Pathways Adrs (CMPS)
Ventyx Biosciences Comm (VTYX)
Tyra Biosciences Comm (TYRA)
Madrigal Pharmaceuticals Comm (MDGL)
Silence Therapeutics Adrs (SLN)

View all positions for TCG Crossover Management

Top funds holding Compass Pathways

Paradigm Biocapital Advisors
ARK Investment Management
Citadel Advisors
Vivo Capital
RA Capital Management
Soleus Capital Management
Aisling Capital Management
Rosalind Advisors
Laurion Capital Management
Barclays
Logos Global Management
Alyeska Investment Group
Nikko Asset Management Americas
Partner Fund Management
Sumitomo Mitsui Trust Holdings

View all funds holding Compass Pathways